Skip to main content
. Author manuscript; available in PMC: 2017 Dec 12.
Published in final edited form as: Drugs. 2017 Feb;77(2):131–144. doi: 10.1007/s40265-016-0685-x

Table 2.

Indications for RAP Testing in HCV-3

Treatment Regimen Presence of Cirrhosis Prior Treatment NS5a RAP Testing Indication
DAC+SOF
+ +
+ +
+ + a
SOF+VEL
+ +
+ +
+ + b
a

Add weight based ribavirin and treat for 24 weeks regardless of presence of NS5a RAP

b

Add weight based ribavirin regardless of presence of NS5a RAP